Alexander Doctoroff, DO
Dermatology · Clark, NJNPI 1881648970
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 859 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 46 manufacturers, the largest accounting for just 9.8% — the pattern of someone who eats at a lot of different presentations.
Across 859 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$2K
- AbbVie$2K
- Sun Pharmaceutical Industries Inc.$1K
- Pfizer$1K
- Incyte Corporation$1K
- Regeneron Healthcare Solutions, Inc.$951
- plus $9K from 40 others
Across 18 payments — averaging $3090.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$53K
- Regeneron$2K
- Almirall LLC$1K
What the payments were for
- Speaking & faculty fees$1841%
- Food & beverage$15,55196%
- Education$5433%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,278 in reported general payments places this provider in the 85th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 22 | $81,234 |
| Tacrolimus | 20 | $5,525 |
| Clobetasol Propionate | 64 | $2,973 |
| Ketoconazole | 117 | $2,116 |
| Metronidazole | 36 | $1,189 |
| Halobetasol Propionate | 20 | $1,178 |
| Clindamycin Phosphate | 32 | $1,130 |
| Imiquimod | 33 | $698 |
| Fluocinonide | 17 | $695 |
| Triamcinolone Acetonide | 71 | $599 |
| Doxycycline Hyclate | 68 | $508 |
| CiclopiroxCiclopirox Olamine | 17 | $428 |
| Mometasone Furoate | 13 | $344 |
| Betamethasone Dipropionate | 11 | $329 |
| Mupirocin | 38 | $230 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Clark
- Omar NoorSomerset$4.5M
- Linda Cappiello-LindsleyHoboken$2.3M
- Brian KeeganEast Windsor$1.7M
- Jerry BagelEast Windsor$1.6M
- Mital Patel CohenFlorham Park$799K
- Ronald BernardinVoorhees$688K
- Brian MachlerFlorham Park$346K
- Jeanine DownieMontclair$327K
- Aanand GeriaRutherford$251K
- Jason MillerFreehold$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.